Literature DB >> 25668622

Improving selection criteria for lung cancer screening. The potential role of emphysema.

Pablo Sanchez-Salcedo1, David O Wilson, Juan P de-Torres, Joel L Weissfeld, Juan Berto, Arantzazu Campo, Ana B Alcaide, Jesús Pueyo, Gorka Bastarrika, Luis M Seijo, Maria J Pajares, Ruben Pio, Luis M Montuenga, Javier J Zulueta.   

Abstract

RATIONALE: Lung cancer (LC) screening using low-dose chest computed tomography is now recommended in several guidelines using the National Lung Screening Trial (NLST) entry criteria (age, 55-74; ≥30 pack-years; tobacco cessation within the previous 15 yr for former smokers). Concerns exist about their lack of sensitivity.
OBJECTIVES: To evaluate the performance of NLST criteria in two different LC screening studies from Europe and the United States, and to explore the effect of using emphysema as a complementary criterion.
METHODS: Participants from the Pamplona International Early Lung Action Detection Program (P-IELCAP; n = 3,061) and the Pittsburgh Lung Screening Study (PLuSS; n = 3,638) were considered. LC cumulative frequencies, incidence densities, and annual detection rates were calculated in three hypothetical cohorts, including subjects who met NLST criteria alone, those with computed tomography-detected emphysema, and those who met NLST criteria and/or had emphysema.
MEASUREMENTS AND MAIN RESULTS: Thirty-six percent and 59% of P-IELCAP and PLuSS participants, respectively, met NLST criteria. Among these, higher LC incidence densities and detection rates were observed. However, applying NLST criteria to our original cohorts would miss as many as 39% of all LC. Annual screening of subjects meeting either NLST criteria or having emphysema detected most cancers (88% and 95% of incident LC of P-IELCAP and PLuSS, respectively) despite reducing the number of screened participants by as much as 52%.
CONCLUSIONS: LC screening based solely on NLST criteria could miss a significant number of LC cases. Combining NLST criteria and emphysema to select screening candidates results in higher LC detection rates and a lower number of cancers missed.

Entities:  

Keywords:  National Lung Screening Trial; emphysema; low-dose computed tomography; lung cancer screening

Mesh:

Year:  2015        PMID: 25668622      PMCID: PMC5447319          DOI: 10.1164/rccm.201410-1848OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  35 in total

1.  Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial.

Authors:  Nanda Horeweg; Carlijn M van der Aalst; Rozemarijn Vliegenthart; Yingru Zhao; Xueqian Xie; Ernst Th Scholten; Willem Mali; Erik Thunnissen; Carla Weenink; Harry J M Groen; Jan-Willem J Lammers; Kristiaan Nackaerts; Joost van Rosmalen; Matthijs Oudkerk; Harry J de Koning
Journal:  Eur Respir J       Date:  2013-07-11       Impact factor: 16.671

Review 2.  Clinical practice. Lung-cancer screening with low-dose computed tomography.

Authors:  Michael K Gould
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

Review 3.  Screening for lung cancer: time for large-scale screening by chest computed tomography.

Authors:  Dekel Shlomi; Ronny Ben-Avi; Gingy Ronen Balmor; Amir Onn; Nir Peled
Journal:  Eur Respir J       Date:  2014-02-13       Impact factor: 16.671

4.  Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.

Authors:  Juan P de Torres; Gorka Bastarrika; Juan P Wisnivesky; Ana B Alcaide; Arantza Campo; Luis M Seijo; Jesús C Pueyo; Alberto Villanueva; María D Lozano; Usua Montes; Luis Montuenga; Javier J Zulueta
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

5.  Targeting of low-dose CT screening according to the risk of lung-cancer death.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

Review 6.  Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.

Authors:  Linda L Humphrey; Mark Deffebach; Miranda Pappas; Christina Baumann; Kathryn Artis; Jennifer Priest Mitchell; Bernadette Zakher; Rongwei Fu; Christopher G Slatore
Journal:  Ann Intern Med       Date:  2013-09-17       Impact factor: 25.391

7.  The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan.

Authors:  David O Wilson; Joel L Weissfeld; Carl R Fuhrman; Stephen N Fisher; Paula Balogh; Rodney J Landreneau; James D Luketich; Jill M Siegfried
Journal:  Am J Respir Crit Care Med       Date:  2008-07-17       Impact factor: 21.405

Review 8.  Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Frank C Detterbeck; Peter J Mazzone; David P Naidich; Peter B Bach
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Economic burden of cancer across the European Union: a population-based cost analysis.

Authors:  Ramon Luengo-Fernandez; Jose Leal; Alastair Gray; Richard Sullivan
Journal:  Lancet Oncol       Date:  2013-10-14       Impact factor: 41.316

Review 10.  Lung Cancer Screening With Low-Dose CT: Its Effect on Smoking Behavior.

Authors:  Meaghan McEntee Gomez; Geri LoBiondo-Wood
Journal:  J Adv Pract Oncol       Date:  2013-11
View more
  30 in total

Review 1.  The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease.

Authors:  Wassim W Labaki; Carlos H Martinez; Fernando J Martinez; Craig J Galbán; Brian D Ross; George R Washko; R Graham Barr; Elizabeth A Regan; Harvey O Coxson; Eric A Hoffman; John D Newell; Douglas Curran-Everett; James C Hogg; James D Crapo; David A Lynch; Ella A Kazerooni; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

2.  Personalized lung cancer screening: the value of spirometry and emphysema as risk modifiers.

Authors:  Firdaus A Mohamed Hoesein; Pim A de Jong
Journal:  Ann Transl Med       Date:  2016-08

3.  Update in Lung Cancer 2015.

Authors:  Avrum Spira; Balazs Halmos; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

4.  Lung cancer screening: how do we make it better?

Authors:  David O Wilson; Juan Pablo de Torres
Journal:  Quant Imaging Med Surg       Date:  2020-02

5.  Optimizing selection of candidates for lung cancer screening: role of comorbidity, frailty and life expectancy.

Authors:  Shailesh Advani; Dejana Braithwaite
Journal:  Transl Lung Cancer Res       Date:  2019-12

Review 6.  Chronic obstructive pulmonary disease (COPD) and lung cancer screening.

Authors:  Robert P Young; Raewyn J Hopkins
Journal:  Transl Lung Cancer Res       Date:  2018-06

Review 7.  Appropriate screening intervals in low-dose CT lung cancer screening.

Authors:  Marjolein A Heuvelmans; Matthijs Oudkerk
Journal:  Transl Lung Cancer Res       Date:  2018-06

Review 8.  Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights.

Authors:  Esther Barreiro; Víctor Bustamante; Víctor Curull; Joaquim Gea; José Luis López-Campos; Xavier Muñoz
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 9.  Lung cancer screening in patients with chronic obstructive pulmonary disease.

Authors:  Jessica Gonzalez; Marta Marín; Pablo Sánchez-Salcedo; Javier J Zulueta
Journal:  Ann Transl Med       Date:  2016-04

10.  Features of COPD as Predictors of Lung Cancer.

Authors:  Laurie L Carr; Sean Jacobson; David A Lynch; Marilyn G Foreman; Eric L Flenaugh; Craig P Hersh; Frank C Sciurba; David O Wilson; Jessica C Sieren; Patrick Mulhall; Victor Kim; C Matthew Kinsey; Russell P Bowler
Journal:  Chest       Date:  2018-02-13       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.